Results for:(40 found)
Nov 6, 2012 2:06PM on Top StocksBy MSN Money Partner

Stocks are higher as Americans head to the polls.

Nov 6, 2012 1:00PM on Top StocksBy MSN Money Partner

Canaccord initiates Kraft Foods with a 'buy' and Mondelez with a 'sell.'

Nov 5, 2012 7:20AM on Top StocksBy Benzinga

The European Central Bank has reportedly broken its own rule, which could spell trouble for Spain.

Oct 9, 2012 12:59PM on Top StocksBy Minyanville.com

Analyst predicts it will take time, however, before Qsymia records meaningful revenue.

Aug 22, 2012 1:44PM on Top StocksBy Zacks.com

The company's virtual coaching helps patients better understand their diseases and therapies.

Tags: ESRXWAG
Jul 26, 2012 11:55AM on Top StocksBy GuruFocus.com

4 stocks the manager of the FPA Crescent Fund keeps acquiring.

Jun 21, 2012 11:30AM on Top StocksBy The Fiscal Times

A company's exposure to Europe is becoming a red flag for many investors.

Jun 8, 2012 1:54PM on Top StocksBy Trefis

The chain suffers for a fifth straight month after the termination of a contract with a key pharmacy benefits manager.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

This stock is up nearly 300%

Puma Biotechnology shares soar after it says it wants to file for marketing approval of an experimental breast cancer drug.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More